Sequential Superiority After Non-Inferiority: Opportunities and Risks

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Bard Medical; Philips; Abiomed; ACIST; Ancora Heart; Edwards Lifesciences; Elixir; Lymphatica</li><li>pension - Abbott</li><li>Equity/Stock(s)/Options - Natera</li></ul>